Literature DB >> 34279787

Aldose Reductase: a cause and a potential target for the treatment of diabetic complications.

Sapna Thakur1, Sonu Kumar Gupta1, Villayat Ali1, Priyanka Singh1, Malkhey Verma2.   

Abstract

Diabetes mellitus, a disorder of metabolism, results in the elevation of glucose level in the blood. In this hyperglycaemic condition, aldose reductase overexpresses and leads to further complications of diabetes through the polyol pathway. Glucose metabolism-related disorders are the accumulation of sorbitol, overproduction of NADH and fructose, reduction in NAD+, and excessive NADPH usage, leading to diabetic pathogenesis and its complications such as retinopathy, neuropathy, and nephropathy. Accumulation of sorbitol results in the alteration of osmotic pressure and leads to osmotic stress. The overproduction of NADH causes an increase in reactive oxygen species production which leads to oxidative stress. The overproduction of fructose causes cell death and non-alcoholic fatty liver disease. Apart from these disorders, many other complications have also been discussed in the literature. Therefore, the article overviews the aldose reductase as the causative agent and a potential target for the treatment of diabetic complications. So, aldose reductase inhibitors have gained much importance worldwide right now. Several inhibitors, like derivatives of carboxylic acid, spirohydantoin, phenolic derivatives, etc. could prevent diabetic complications are discussed in this article.
© 2021. The Pharmaceutical Society of Korea.

Entities:  

Keywords:  Aldose reductase; Aldose reductase inhibitors; Diabetic complications; Hyperglycaemic conditions; Sorbitol dehydrogenase

Mesh:

Substances:

Year:  2021        PMID: 34279787     DOI: 10.1007/s12272-021-01343-5

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  48 in total

1.  Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE).

Authors:  Shahid P Baba; Jason Hellmann; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Chem Biol Interact       Date:  2011-01-27       Impact factor: 5.192

2.  Inhibition of aldose reductase and anti-cataract action of trans-anethole isolated from Foeniculum vulgare Mill. fruits.

Authors:  Vandana Dongare; Chaitanya Kulkarni; Manish Kondawar; Chandrakant Magdum; Vivek Haldavnekar; Akalpita Arvindekar
Journal:  Food Chem       Date:  2011-11-10       Impact factor: 7.514

3.  Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.

Authors:  Xin Chen; Yanchun Yang; Bing Ma; Shuzhen Zhang; Minlan He; Dequan Gui; Saghir Hussain; Chaojun Jing; Changjin Zhu; Qun Yu; Yan Liu
Journal:  Eur J Med Chem       Date:  2011-03-01       Impact factor: 6.514

Review 4.  Diabetic retinopathy--biomolecules and multiple pathophysiology.

Authors:  Haseeb Ahsan
Journal:  Diabetes Metab Syndr       Date:  2014-10-24

5.  Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice.

Authors:  Alvin K H Cheung; Maggie K L Fung; Amy C Y Lo; Terence T L Lam; Kwok Fai So; Stephen S M Chung; Sookja K Chung
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

6.  Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors.

Authors:  Francesco Balestri; Luca Quattrini; Vito Coviello; Stefania Sartini; Federico Da Settimo; Mario Cappiello; Roberta Moschini; Antonella Del Corso; Umberto Mura; Concettina La Motta
Journal:  Cell Chem Biol       Date:  2018-08-16       Impact factor: 8.116

7.  Role of aldose reductase in diabetes-induced retinal microglia activation.

Authors:  Kun-Che Chang; Biehuoy Shieh; J Mark Petrash
Journal:  Chem Biol Interact       Date:  2019-01-23       Impact factor: 5.192

8.  Exploration of thioxothiazolidinone-sulfonate conjugates as a new class of aldehyde/aldose reductase inhibitors: A synthetic and computational investigation.

Authors:  Hina Andleeb; Yildiz Tehseen; Farrukh Jabeen; Imtiaz Khan; Jamshed Iqbal; Shahid Hameed
Journal:  Bioorg Chem       Date:  2017-08-31       Impact factor: 5.275

Review 9.  Molecular mechanism of diabetic neuropathy and its pharmacotherapeutic targets.

Authors:  Saikat Dewanjee; Sonjit Das; Anup Kumar Das; Niloy Bhattacharjee; Anjum Dihingia; Tarun K Dua; Jatin Kalita; Prasenjit Manna
Journal:  Eur J Pharmacol       Date:  2018-06-30       Impact factor: 4.432

10.  Astaxanthin inhibits aldose reductase activity in Psammomys obesus, a model of type 2 diabetes and diabetic retinopathy.

Authors:  Maha Benlarbi-Ben Khedher; Khouloud Hajri; Ahmed Dellaa; Basma Baccouche; Imane Hammoum; Nourhene Boudhrioua-Mihoubi; Wissal Dhifi; Rafika Ben Chaouacha-Chekir
Journal:  Food Sci Nutr       Date:  2019-11-12       Impact factor: 2.863

View more
  5 in total

1.  Models of enzyme inhibition and apparent dissociation constants from kinetic analysis to study the differential inhibition of aldose reductase.

Authors:  Francesco Balestri; Mario Cappiello; Roberta Moschini; Umberto Mura; Antonella Del-Corso
Journal:  J Enzyme Inhib Med Chem       Date:  2022-12       Impact factor: 5.756

Review 2.  Physiological and Pathological Roles of Aldose Reductase.

Authors:  Mahavir Singh; Aniruddh Kapoor; Aruni Bhatnagar
Journal:  Metabolites       Date:  2021-09-27

3.  Dual Targeting of PTP1B and Aldose Reductase with Marine Drug Phosphoeleganin: A Promising Strategy for Treatment of Type 2 Diabetes.

Authors:  Massimo Genovese; Concetta Imperatore; Marcello Casertano; Anna Aiello; Francesco Balestri; Lucia Piazza; Marialuisa Menna; Antonella Del Corso; Paolo Paoli
Journal:  Mar Drugs       Date:  2021-09-24       Impact factor: 5.118

4.  Implications of Diabetes-Induced Altered Metabolites on Retinal Neurodegeneration.

Authors:  Dalia I Aldosari; Ajamaluddin Malik; Abdullah S Alhomida; Mohammad S Ola
Journal:  Front Neurosci       Date:  2022-07-13       Impact factor: 5.152

Review 5.  The Good, the Bad and the New about Uric Acid in Cancer.

Authors:  Simone Allegrini; Mercedes Garcia-Gil; Rossana Pesi; Marcella Camici; Maria Grazia Tozzi
Journal:  Cancers (Basel)       Date:  2022-10-10       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.